News | July 26, 2024
Cupid widens e-Commerce presence on leading Indian platforms
This strategic move aims to make Cupid's high-quality products more accessible to consumers nationwide
This strategic move aims to make Cupid's high-quality products more accessible to consumers nationwide
Acquisition in line with Mankind’s stated objective to expand its presence in high entry barrier complex portfolios and high potential OTX brands
Giroctocogene fitelparvovec study meets primary and key secondary objectives of superiority compared to prophylaxis
Glenmark Life Sciences has reported total income of Rs. 594.109 crores during the period ended June 30, 2024
A one-time dose of DURVEQTIX has reduced bleeds post-treatment compared to standard of care with a median annualized bleed rate (ABR) of zero bleeds (range 0 to 9.9)
Leqselvi delivered statistically significant efficacy across two Phase 3 clinical trials
EBITDA grew by 31% YoY with EBITDA margin of 11%, a YoY improvement of over 170bps vs. Q1FY24
Laurus Labs has reported total income of Rs. 1,197.42 crores during the period ended June 30, 2024
The product is bioequivalent and therapeutically equivalent to the reference listed drug
Shilpa Biologicals has developed high concentration adalimumab (100 mg/mL)
Subscribe To Our Newsletter & Stay Updated
